MyoKardia

1 follower


MyoKardia, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction.

Industries

Headquarters

Stage

Employees

Links

Org chart

Tassos Gianakakos

Collapse
Barbara Troupin
SVP, Medical Affairs
Denelle Waynick
General Counsel & Corporate Secretary
Ingrid Boyes
Chief Human Resources Officer
Jake Bauer
Chief Business Officer
Jay Engelberg
Chief Medical Officer
Joseph Lambing
SVP, Nonclinical and Pharmaceutical Development
Marc Semigran
SVP, Medical Sciences
Robert S. Mcdowell
Chief Scientific Officer
Taylor C. Harris
Chief Financial Officer
William C. Fairey
Executive Vice President, Chief Commercial Officer
Holly Schachner
SVP, Therapeutic Area